Funding · Company
Alveus Therapeutics, Inc.
Philadelphia, PABiotech & Pharma
Alveus Therapeutics, Inc. of Philadelphia, PA has disclosed $57M across 1 Form D offering filed with the SEC on Jan 14, 2026.
$57M
Total disclosed
1
Form D offering
2023
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$57M
Form D · Jan 14, 2026 ↗
Q1 2026
· target $111M
Filing details
HeadquartersPhiladelphia, PAIndustryBiotech & Pharma (Pharmaceuticals)Incorporated2023SEC CIK0002075856Offerings on file1
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →